Senior Director, FTI Consulting
Kimberly Ha is a Senior Director in the FTI Consulting Strategic Communications segment and is based in New York. She is an award-winning journalist and has nearly 10 years of experience in healthcare and financial journalism. Kimberly also serves on a number of advisory boards in the life sciences industry.
Kimberly was previously Global Editor at BioPharm Insight, an independent business intelligence product launched by the Mergermarket Group. She started her career as a financial journalist in Hong Kong specializing in life sciences M&A at Mergermarket and was the lead sector specialist before transferring to New York to launch the business intelligence division for BioPharm Insight in 2007. Kimberly has been a sought-after panelist and moderator at major healthcare investor conferences and events, including the Prix Galien Forum, Biotech Showcase, Life Sciences Summit, and others.
Among other topics, this session will cover: Working with an informed consumer The ‘retail mindset’ transforming healthcare How big pharma partners with startups What are the new and innovative technologies that are appealing to big pharma How has pharma’s partnership strategy evolved over time? What does Pharma care about most while looking at early stage investments? […]
Among other topics, this session will cover the following: One advantage of cloud-based SaaS applications is the ability to perform data mining across large and often disperse caches of data. With concerns about HIPAA and data security, however, healthcare organizations are notoriously protective of their data. Are we moving towards greater data liberalization in healthcare? […]